Moderna names former PerkinElmer exec as new CFO
2022.08.17 16:09
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder/File Photo
(Reuters) – Moderna (NASDAQ:MRNA) Inc on Wednesday named former PerkinElmer (NYSE:PKI) executive James Mock as its new finance chief, months after the abrupt exit of former CFO Jorge Gomez.
The COVID-19 vaccine maker had appointed Dentsply Sirona’s Gomez as finance chief in April, but he left his position a day after taking charge the next month.
Gomez’s departure followed an investigation launched by his former employer, Moderna said.
Following the exit, former Moderna CFO David Meline returned from his recent retirement to take over the role.
Moderna on Wednesday said Mock would start as finance chief from Sept. 6. Meline would retire on the same day but shall remain as a consultant through the transition.
Before joining Moderna, Mock was the chief financial officer of PerkinElmer, a life sciences and diagnostics company.
